SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
SOPHiA GENETICS (Nasdaq:SOPH) announced leadership will present at TD Cowen's 46th Annual Health Care Conference in Boston.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SOPHiA GENETICS (Nasdaq:SOPH) announced leadership will present at TD Cowen's 46th Annual Health Care Conference in Boston.
Jurgi Camblong, CEO and co-founder, and Ross Muken, President, will participate in a fireside chat on March 4, 2026 at 10:30 am EST / 4:30 pm CET. According to the company, a live audio webcast will be available and a replay will be accessible for 90 days after the event.
Details
News Market Reaction – SOPH
On Feb 25, the day this news came out, SOPH closed 1.32% above the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
Key Figures
- Conference date
- March 4, 2026
- TD Cowen Health Care Conference fireside chat date
- Session time (EST)
- 10:30 am EST
- Scheduled time for conference fireside chat
- Session time (CET)
- 4:30 pm CET
- Corresponding European time for fireside chat
- Webcast replay window
- 90 days
- Duration webcast replay remains available after event
Historical Context
-
Announcement of upcoming Q4 and full-year 2025 results call date.
-
Signing of two major U.S. integrated health systems to SOPHiA network.
-
Recognition via multiple innovation awards for product advances.
-
Preliminary 2025 results, 2026 guidance, and executive transition plan.
-
Strategic collaboration with MD Anderson on AI-based precision oncology.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the fireside chat will be available here. Additionally, a replay of the webcast will be available for 90 days following the event.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDMTM, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-present-at-the-46th-annual-td-cowen-health-care-conference-302696166.html
SOURCE SOPHiA GENETICS
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.